RecruitingNot ApplicableNCT07382323

Metacognitive Therapy Compared to Cognitive-behavioral Therapy

Transdiagnostic Metacognitive Therapy Compared to Disorder-specific Cognitive-behavioral Therapy for Anxiety Disorders: a Qualitative Study

Sponsor

Karolinska Institutet

Enrollment

30 participants

Start Date

Jan 28, 2026

Study Type

INTERVENTIONAL

Conditions

Social Anxiety Disorder Generalized Anxiety Disorder Posttraumatic Stress Disorder (PTSD)

Summary

This is a qualitative study of participants who have taken part in a randomized controlled trial comparing transdiagnostic metacognitive therapy and disorder-specific cognitive-behavioral therapy for anxiety disorders. The purpose of the study is to explore participant perceptions of the respective treatment models to facilitate implementation and dissemination of the treatments.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Disorder-specific cognitive-behavioral therapy and a behavioral approach called Transdiagnostic metacognitive therapy for people with generalized anxiety disorder, posttraumatic stress disorder (ptsd), and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.